Ekso Bionics Holdings EKSO is preparing to release its quarterly earnings on Monday, 2024-10-28. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Ekso Bionics Holdings to report an earnings per share (EPS) of $-0.10.
The market awaits Ekso Bionics Holdings's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Earnings History Snapshot
Last quarter the company missed EPS by $0.00, which was followed by a 28.62% drop in the share price the next day.
Here's a look at Ekso Bionics Holdings's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.13 | -0.16 | -0.11 | -0.31 |
| EPS Actual | -0.13 | -0.20 | -0.22 | -0.24 |
| Price Change % | -28.999999999999996% | -4.0% | -25.0% | 6.0% |
Stock Performance
Shares of Ekso Bionics Holdings were trading at $1.02 as of October 24. Over the last 52-week period, shares are up 3.42%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.
To track all earnings releases for Ekso Bionics Holdings visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
